The Middleby Corporation (NASDAQ: MIDD) announced the appointment of Glenn Eisenberg to its board of directors, effective March 1. The addition expands Middleby's board to twelve members.

Eisenberg brings extensive public company leadership experience across life sciences, industrial manufacturing, and diversified industrial sectors. He most recently served as executive vice president and chief financial officer at Labcorp (NYSE: LH), a global life sciences company with $13 billion in revenue, overseeing financial operations across more than 100 countries until his retirement in December 2024. He continues as a special advisor to Labcorp.

Prior to Labcorp, Eisenberg served as executive vice president of finance and administration and chief financial officer from 2002-2014 at The Timken Company, a manufacturer of engineered bearings, alloy steels and related products. Earlier in his career, he was president and chief operating officer of United Dominion Industries, a diversified industrial manufacturer now owned by SPX Corporation, where he also held senior finance roles.

Eisenberg currently serves on the boards of two other public companies. He joined Solventum's (NYSE: SOLV) board in April 2024, where he chairs the audit committee. He was added to Lumexa Imaging's (NASDAQ: LMRI) board in March 2025, chairing the audit committee and serving on the compensation committee. His previous board experience includes roles at Alpha Natural Resources Inc., U.S. Ecology Inc., Family Dollar Stores Inc., and Perspecta Inc.

"Glenn's appointment reflects our strategic focus on enhancing board capabilities with complementary financial and operational expertise," said Gordon O'Brien, Middleby board chairman.

The information is based on a company press release statement.